Literature DB >> 18484927

Racial disparities in infection-related mortality at Alice Springs Hospital, Central Australia, 2000--2005.

Lloyd J Einsiedel1, Liselle A Fernandes, Richard J Woodman.   

Abstract

OBJECTIVE: To compare infection-related mortality rates and pathogens isolated for Indigenous and non-Indigenous adult patients at Alice Springs Hospital (ASH). DESIGN, PARTICIPANTS AND
SETTING: Retrospective study of inhospital deaths of adults (patients aged > or = 15 years) associated with an infection during a medical or renal admission to ASH between 1 January 2000 and 31 December 2005. MAIN OUTCOME MEASURES: Admission- and population-based infection-related mortality rates and mortality rate ratios (MRRs) for Indigenous versus non-Indigenous adults.
RESULTS: There were 513 deaths, of 351 Indigenous and 162 non-Indigenous patients. For Indigenous patients, 60% of deaths were infection-related, compared with 25% for non-Indigenous patients (P < 0.001). The admission-based infection-related MRR for Indigenous versus non-Indigenous adults was 2.2 (95% CI, 1.6-3.1) (15.3 v 6.8 deaths per 1000 admissions; P < 0.001). After adjusting for age and year of death, the population-based infection-related MRR was 11.3 (95% CI, 8.0-15.8) overall (351 v 35 deaths per 100,000 population; P < 0.001) and 31.5 (95% CI, 16.1-61.8) for patients aged < 60 years. The median age of patients who died with an infection was 49 (interquartile range [IQR], 38-67) years for Indigenous and 73 (IQR, 58-80) years for non-Indigenous patients (P < 0.001). For Indigenous patients, 56% of infection-related deaths were associated with bacterial sepsis, with half of these due to enteric organisms. Other deaths followed chronic hepatitis B infection, invasive fungal infections and complications of strongyloidiasis.
CONCLUSION: Indigenous patients at ASH are 11 times more likely than non-Indigenous patients to die with an infectious disease. This racial disparity reflects the ongoing socioeconomic disadvantage experienced by Indigenous Australians.

Entities:  

Mesh:

Year:  2008        PMID: 18484927

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  6 in total

1.  Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population.

Authors:  Lloyd Einsiedel; Tim Spelman; Emma Goeman; Olivier Cassar; Mick Arundell; Antoine Gessain
Journal:  PLoS Negl Trop Dis       Date:  2014-01-16

Review 2.  Strongyloides stercoralis: systematic review of barriers to controlling strongyloidiasis for Australian indigenous communities.

Authors:  Adrian Miller; Michelle L Smith; Jenni A Judd; Rick Speare
Journal:  PLoS Negl Trop Dis       Date:  2014-09-25

3.  Non-communicable diseases, infection and survival in a retrospective cohort of Indigenous and non-Indigenous adults in central Australia.

Authors:  Lloyd Einsiedel; Liselle Fernandes; Sheela Joseph; Alex Brown; Richard J Woodman
Journal:  BMJ Open       Date:  2013-07-19       Impact factor: 2.692

4.  Paediatric Strongyloidiasis in Central Australia.

Authors:  Angela Wilson; Deborah Fearon
Journal:  Trop Med Infect Dis       Date:  2018-06-13

Review 5.  Argument for Inclusion of Strongyloidiasis in the Australian National Notifiable Disease List.

Authors:  Meruyert Beknazarova; Harriet Whiley; Jenni A Judd; Jennifer Shield; Wendy Page; Adrian Miller; Maxine Whittaker; Kirstin Ross
Journal:  Trop Med Infect Dis       Date:  2018-06-05

6.  Association of Built Environmental Features with Rates of Infectious Diseases in Remote Indigenous Communities in the Northern Territory, Australia.

Authors:  Amal Chakraborty; Victor Maduabuchi Oguoma; Neil T Coffee; Peter Markey; Alwin Chong; Margaret Cargo; Mark Daniel
Journal:  Healthcare (Basel)       Date:  2022-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.